Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NEXN regulates vascular smooth muscle cell phenotypic switching and neointimal hyperplasia
Zexuan Lin, Chaojie Wang, Zhuohua Wen, Zhaohui Cai, Wenjie Guo, Xin Feng, Zengyan Huang, Rongjun Zou, Xiaoping Fan, Canzhao Liu, Hanyan Yang
Zexuan Lin, Chaojie Wang, Zhuohua Wen, Zhaohui Cai, Wenjie Guo, Xin Feng, Zengyan Huang, Rongjun Zou, Xiaoping Fan, Canzhao Liu, Hanyan Yang
View: Text | PDF
Research Article Cell biology Vascular biology

NEXN regulates vascular smooth muscle cell phenotypic switching and neointimal hyperplasia

  • Text
  • PDF
Abstract

Vascular smooth muscle cells (VSMCs) exhibit substantial heterogeneity and plasticity, enabling them to switch between contractile and synthetic states, which is crucial for vascular remodeling. Nexilin (NEXN) has been identified as a high-confidence gene associated with dilated cardiomyopathy. Existing evidence indicates NEXN is involved in phenotypic switching of VSMCs. However, a comprehensive understanding of the cell-specific roles and precise mechanisms of NEXN in vascular remodeling remains elusive. Using integrative transcriptomics analysis and smooth muscle–specific lineage-tracing mice, we demonstrated NEXN was highly expressed in VSMCs, and the expression of NEXN was significantly reduced during the phenotypic transformation of VSMCs and intimal hyperplasia induced by vascular injury. VSMC-specific NEXN deficiency promoted the phenotypic transition of VSMCs and exacerbated neointimal hyperplasia in mice following vascular injury. Mechanistically, we found NEXN primarily mediated VSMC proliferation and phenotypic transition through endoplasmic reticulum (ER) stress and Krüppel-like factor 4 signaling. Inhibiting ER stress ameliorated VSMC phenotypic transition by reducing cell cycle activity and proliferation caused by NEXN deficiency. These findings indicate targeting NEXN could be explored as a promising therapeutic approach for proliferative arterial diseases.

Authors

Zexuan Lin, Chaojie Wang, Zhuohua Wen, Zhaohui Cai, Wenjie Guo, Xin Feng, Zengyan Huang, Rongjun Zou, Xiaoping Fan, Canzhao Liu, Hanyan Yang

×

Figure 6

NEXN knockdown in VSMCs augments ER stress, modulating the VSMC phenotype via the ATF4/Krüppel-like factor 4 signaling axis.

Options: View larger image (or click on image) Download as PowerPoint
NEXN knockdown in VSMCs augments ER stress, modulating the VSMC phenotyp...
(A) GOBPs and KEGG enrichment analysis of DEGs in NC- or si-NEXN–pretransfected HASMCs treated with PDGF-BB. n = 3 for each group. (B) GSEA-based GO analysis enrichment plots of vascular associated smooth muscle contraction. (C) GSEA-based GO analysis enrichment plots of DNA replication-dependent chromatin organization. (D) Transmission electron microscopy images of VEC- or Ad-NEXN–preinfected HASMCs treated with PDGF-BB. Arrows indicate the ER. Scale bar: top = 5 μm; bottom = 1 μm. (E) Immunoblotting and quantification of ER stress indicators (ATF4 and CHOP) in lysates of NC or si-NEXN pretransfected HASMCs treated with PDGF-BB for 24 hours. n = 6 for each group. KLF4, Krüppel-like factor 4. (F) Immunoblotting and quantification of KLF4 in lysates of NC- or si-NEXN–pretransfected HASMCs treated with PDGF-BB for 24 hours. n = 3 for each group. (G and H) Immunoblotting (G) and quantification (H) of ER stress indicators (ATF4 and CHOP) and KLF4 expression in lysates prepared from either sham-operated right common carotid arteries or injured left common carotid arteries of Ctrl and NexnismKO mice. n = 6 for each group. Data are represented as mean ± SEM. Statistical analyses were performed using unpaired, 2-tailed Student’s t tests. *P < 0.05, **P < 0.01 for indicated comparisons.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts